News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Emyria.
RELATED STOCKHEAD STORIES
Health & Biotech
Cann Group, Emyria team up in bid to gain TGA approval for low-dose CBD gelcap
News
IPO Watch: Two gold explorers lead a pack of ASX debuts in January
Health & Biotech
Cann Group just bought some exclusive access to Europe’s biggest medicinal cannabis market
IPO Watch
IPO Watch: ASX IPOs in 2020 up 42 per cent on average; here are the top performers
News
Rise and Shine: What you need to know before the ASX opens
IPO Watch
IPO Watch: The ASX IPO pipeline snakes well into January
Health & Biotech
Here’s how pot execs think the UN’s big cannabis shift can affect pot stocks in Australia
IPO Watch
IPO Watch: There are still 20+ more new listings to come on the ASX in 2020
Health & Biotech
Expert views on TGA’s latest Cannabis ruling
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Experts
Scopo’s powerplays: Investors love an ice queen
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Reality defying S&P 500 flirts with record high
News
10 at 10: These ASX stocks are taking flight this morning
Guides
Cannabis stocks guide: Here’s everything you need to know
News
